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Introduction
Familial Mediterranean fever (FMF) is an autoinflamma-
tory disease which is characterized by recurrent episodes
of typical attacks with fever and abdominal pain. The
pathophysiology shows an ineffective pyrin which leads to
brakeless inflammation. It is not exactly known which fac-
tors lead to initiation of the attacks. Furthermore there
seems to be sustained inflammation between the attacks.
IL-18 is acytokinethat belongs to theIL-1superfamily and
is produced bymacrophagesand other cells. It plays an
important role in the initiation and maturation of the
inflammasome and is therefore able to induce severein-
flammatory reactions.
Objectives
In our study we aimed to clarify the cytokine profiles of
patients with genetically confirmed FMF in mainly attack
free periods and compare it with healthy controls.
We evaluated type 1 cytokines: IFN-g, TNF-b, type 2
cytokines: IL-5, IL-10, IL-13 and other inflammatory cyto-
kines: IL-1, IL-6, IL-17, IL-18, TNF-a and GMCSF.
Patients and methods
We examined 42 samples of 36 FMF patients between 07/
2008 and 03/2015. Six patients were evaluated at two
time-points. Ten healthy subjects were examined as con-
trol group. The levels of the cytokines were determined by
commercial ELISA kits.
Results
The mean age of the FMF patients was 34,1 years, 43 %
with homozygotic and 57 % with combined heterozygotic
mutations.
Serum levels of IL-18 (normal range up to 400pg/ml)
were 1946 pg/ml in mean for FMF patients. None of the
controls showed an increased level. Serum levels of
homozygotic patients were with 3654 pg/ml (mean
value) higher than in patients with combined heterozy-
gotic mutations (1290 pg/ml).
Patients with a complicated form of FMF (no colchi-
cine response, therapy with IL-1 antibody) have the
highest values of IL-18 (4233 pg/ml mean). It remains
unclear if this is a consequence of IL-1 antibody treat-
ment or active disease. All of the eight FMF patients
which showed no increase in IL-18, had only a mild dis-
ease-activity and heterozygotic mutations.
All other cytokines showed no significant differences
between the FMF patients and the control group with a
tendency of higher IL-10 and IL-13 levels. IL-1 and IL-6
levels were not elevated. The results of the 6 patients
which were evaluated at two time-points showed repeti-
tive and comparable results.
Conclusion
Our results suggest a major role of Interleukin 18 in
pathogenesis and disease course of familial Mediterra-
nean fever. Further studies need to clarify the specific
role of IL-18 and the option as a potential marker for
severe disease and a target for therapy in FMF patients.
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